Based on the above analysis, we predict that CCNE1 and E2F1 holds the potential to be diagnostic/prognostic markers of NSCLC and DMDD might inhibit the development of lung cancer by targeting CCNE1 and E2F1. This evidence concerns the gene CCNE1 and lung carcinoma.